Stay updated with breaking news from Pharma Mar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Spanish pharmaceutical group PharmaMar posted a 32% drop in annual net profit on Monday after the company recorded its best ever results in 2020 thanks to unprecedented growth in its oncology drugs... | February 28, 2022
Jazz Pharmaceuticals Announces First Quarter 2021 Financial Results Continued Zepzelca Growth Across Second-Line SCLC Setting Xywav in Idiopathic Hypersomnia Granted FDA Priority Review and an August 12, 2021, PDUFA Target Action Date On Track to Close Acquisition of GW Pharmaceuticals plc in Early May, Creating an Innovative, High-Growth, Global Biopharma Leader Secured $5.35 Billion Financing Including $1.5 Billion Senior Secured Notes in Connection with GW Acquisition 23% of Revenue from Recently Launched Products; Total Revenues Increased 14% to $607.6 Million Compared to First Quarter 20...
News TECNALIA ranked third in the list of Spanish organisations that applied for the most European patents in 2020 7 April 2021 TECNALIA has a portfolio of 192 patent families (783 patents) and 13 investee companies, which create 207 direct jobs. For the fifth consecutive year, TECNALIA was once again one of the top organisations in Spain in terms of the number of applications for European patents (click here for the historical record). Specifically, TECNALIA came in in third place with 17 European patent applications, behind CSIC (72) and Amadeus (60), the same as Laboratorios Esteve (17) an...
La farmacéutica española PharmaMar va a realizar un ensayo clínico de fase III con un compuesto para la enfermedad de ojo seco tras recibir la autorización de las autoridades de Estados Unidos.
FDA Breakthrough Therapy Designation in MAGE-A4 expressing patients. The Synovial Sarcoma market is expected to show positive growth, mainly ascribed to the increased prevalence and the anticipated launch of novel therapies, such as Anlotinib, ADP-A2M4, For further information on Market Impact by Therapies, visit: Synovial Sarcoma, also known as malignant synovioma, can originate from different soft tissue types, such as muscle or ligaments. It is a high-grade tumor and spreads to distant sites. Synovial Sarcoma symptoms depend on where the tumor forms. The disease is often first noticed a...